Gabriel Zada, MD, MS

#EICHighlight: John A. Jane (1992-2013), the sixth editor-in-chief of the JNS, innovatively established JNS Spine and JNS Pediatrics and endorsed electronic publishing endeavors through Neurosurgical Focus while emphasizing the importance of iterative peer review.

We are so fortunate to have Dr Chow and colleagues like Maria Quiban at Good Day LA to help raise awareness for #BrainTumors! @USCBTC @NeurosurgeryUSC #Neurosurgery

📢 New Study from @NeurosurgeryUSC : Neurosurgery Match Enters the Signaling Era 🧠📬 Published in @TheJNS Neurosurgery residency applicants are submitting fewer applications & receiving fewer interviews — yet matching more efficiently — thanks to preference signaling. 📊 Key…

Had a fun time lecturing at the @PituitarySoc Congress meeting in San Francisco today in a dedicated session for the International Society of Pituitary Surgeons (#ISPS) along with these esteemed neurosurgeon colleagues! @ManishKAghi @drjfm_stanford @DanielYoshor Nelson Oyesiku…

Scientists have developed a framework that can guide a #surgical robot through multiple steps involved in gall bladder removal in pigs #autonomously. @krieger_axel @jwbkim Learn more in Science #Robotics: scim.ag/44Dhska

🚨 NEW STUDY from our team @USCBTC published in Operative Neurosurgery!   Catalogue & Evolution of Minimally Invasive (MIS) Approaches for Adult Intracranial Pathology From 2011-23.   💡Bottom line: MIS isn’t the future — it’s the standard of care for many cranial pathologies.…

🔬 NEW research from the USC Pituitary Center + @USCBTC Are lumbar drains safe during complex endonasal skull base surgery? In our 10-year retrospective study, selective lumbar drain (LD) use in high-risk endoscopic endonasal surgery (EES) was generally safe & well tolerated.…

Higher volume helps. 📊 Our new analysis of ~15,000 patients undergoing endoscopic transsphenoidal surgery (ETSS) for pituitary tumors published in @TheJNS shows: 🏥 Higher institutional volume --> lower risk •Major complications steadily drop as case volume rises until ~58…

🧠 New research from the lab of Dr. Gabriel Zada at the USC Brain Tumor Center reveals the hidden complexity behind how brain tumors survive and grow. The study, conducted in collaboration with USC Norris Comprehensive Cancer Center, found that glioblastoma tumors can harbor…

🧠 New Pituitary Society Consensus Statement published in @Nature Reviews Endocrinology – here’s what to know about Pituitary Incidentalomas: 🔍 Found by accident, often benign 🧪 Hormone panel recommended for all (prolactin, IGF‑1, cortisol, pituitary axes) 🧠 Dedicated Sellar…

🎓 Congrats to the 3 Cs — Drs. Cavaleri, Chartrain, and Chung — on successfully completing 7 years of neurosurgery residency training! I remember Intern Bootcamp like it was yesterday. Job well done! These 3 talented surgeons exemplify Confidence, Character & Collaboration, and…

🧠💡 Breakthrough research from our @USCBTC team + @cityofhope published in @Nature Communications reveals how gliomas may outsmart treatment. We used cutting-edge spatial genomics to discover that glioblastomas contain hidden DNA "rebels" called extrachromosomal DNA (ecDNA) that…

Big things happen when great minds come together. 💡🧠 Yesterday, we welcomed the leadership team from the American Brain Tumor Association to the USC Brain Tumor Center for a powerful day of collaboration. From cutting-edge research to critical funding needs, we explored how we…

🧠 Why does examining brain tissue matter? Dr. Kyle Hurth, a neuropathologist at the USC Brain Tumor Center, breaks down why looking at brain tissue under the microscope is essential for getting an accurate diagnosis. Imaging can tell us a lot—but it’s the tissue that tells the…

🧠 New research reveals a promising combo therapy for glioblastoma — one of the deadliest brain cancers. TTFields + immunotherapy + chemo may help extend survival. Find out more: bit.ly/4e08qSy

#EICHighlight: Thoralf Sundt, Jr. (1989-1992), the fifth editor-in-chief of the JNS, was proud of the selectivity and quality of its papers. He processed submissions quickly and provided specific advice to authors on how to improve papers that he was unable to publish.

Treatment Spotlight: LITT Laser Interstitial Thermal Therapy is a minimally invasive technique using heat to destroy tumor cells — offering hope to patients who may not be candidates for traditional surgery. We’re proud to offer this cutting-edge approach at the Brain Tumor…

#EICHighlight: Henry Schwartz (1975-1985), the third editor-in-chief of the JNS, personally reviewed all submissions, providing authors of rejected manuscripts with advice and ensuring authors revised manuscripts satisfactorily. He improved the journal's business operations.

Today is Clinical Trials Day. Behind every breakthrough in medicine is a clinical trial—and behind every clinical trial is a community of researchers, physicians, coordinators, and most importantly: patients. Clinical trials are where hope meets evidence. Where “what if”…